https://www.healio.com/news/rheumatology/20220805/biosimilars-to-shake-up-us-drug-market-in-2023-and-beyond-despite-problem-of-complexity
0
0
8/8/22 at 9:35am
Organization
Healio
Authors
ORLANDO, Fla. — Despite the glacial pace of biosimilar uptake in the United States so far, their use is expected to cut drug costs by $54 billion over the next decade, noted a presenter at the 2022 Rheumatology Nurses Society Conference.“We think …
Create an account
or login to join the discussion